SCOLR Pharma, Inc. (DDD) Announces Issuance of European Patent for CDT® Ibuprofen
7/11/2012 10:28:36 AM
More...
|
SCOLR Pharma, Inc. (DDD) Launches Redesigned Website to Support Their CDT® Formulated Supplements
6/26/2012 11:50:39 AM
More...
|
SCOLR Pharma, Inc. (DDD) Welcomes Clem Calabrese as Director of Field Sales
5/1/2012 12:39:19 PM
More...
|
SCOLR Pharma, Inc. (DDD)'s Partner Announces Successful Results in Pivotal Bioequivalence Trial and Plans for a Pre-NDA Meeting
4/19/2012 10:50:01 AM
More...
|
SCOLR Pharma, Inc. (DDD)'s Partner Announces Positive Preliminary Results in Ondansetron Study
4/10/2012 7:35:34 AM
More...
|
SCOLR Pharma, Inc. (DDD) Provides Product Information on Website
3/6/2012 9:08:28 AM
More...
|
SCOLR Pharma, Inc. (DDD) Launches Cutting Edge Nutritional Products at Major Retailers in 2012
2/17/2012 9:41:43 AM
More...
|
SCOLR Pharma, Inc. (DDD)'s Partner to Commence Bioequivalence Study of Ondansetron
2/15/2012 9:39:08 AM
More...
|
SCOLR Pharma, Inc. (DDD) Announces Initial Shipments of Its Nutritional Products
12/28/2011 10:18:35 AM
More...
|
SCOLR Pharma, Inc. (DDD) Announces Third Quarter 2011 Financial Results
11/11/2011 5:46:32 AM
More...
|
|